MaxLinear price target raised to $25 from $22 at Susquehanna

Susquehanna analyst Christopher Rolland raised the firm’s price target on MaxLinear to $25 from $22 and keeps a Positive rating on the shares. The firm met with management and although visibility is generally low, conversations were focused around channel inventory, lackluster macro especially in China, various stages of the downcycle per end market, and the overall 2024 outlook.